In this National Emerging Special Pathogen Training and Education Center webinar attendees will discuss current evidence surrounding clinical trials for COVID-19 therapeutics including ACTT1, ACTT2, and ACTT3, and describe the FDA's Coronavirus Treatment Acceleration Program (CTAP) when determining new treatments for COVID that are deemed safe and effective. Register Here Please see here for a […]